Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002066359 | SCV002441686 | likely benign | Rubinstein-Taybi syndrome | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV004546588 | SCV005042473 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | CREBBP: BP4 |
Prevention |
RCV003935916 | SCV004754969 | likely benign | CREBBP-related disorder | 2019-07-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |